Efficacy and safety of inhibitory magnetic stimulation in the treatment of refractory erythema of rosacea: a prospective, randomized, controlled clinical trial

doi:10.1016/j.jaad.2026.07.036

Efficacy and safety of inhibitory magnetic stimulation in the treatment of refractory erythema of rosacea: a prospective, randomized, controlled clinical trial

Journal: Journal of the American Academy of Dermatology (Q1)
Published: 17 July 2026
Study design: Randomized controlled trial
Evidence level: Level 1, High (CEBM 1b)
Authors: Ziye Yang, Ben Wang, Zhixiang Zhao, Wei Shi, Dan Jian, Yan Tang, et al.
PMID: 42468666
DOI: 10.1016/j.jaad.2026.07.036

Why clinicians should know about it

Picked for Dermatology (top studies of the week, 19 July 2026): RCT of magnetic stimulation for rosacea, dermatology relevance

View on PubMed Full text at the publisher Open in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.